Position in SNDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,985,024
+$1,293,676 QoQ
Shares Held
1,051,465
+13.2% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#31
of 238 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. SNDX ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in SNDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,985,024 | 1,051,465 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,691,348 | 928,568 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,499,128 | 928,088 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,319,834 | 930,766 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,564,287 | 1,021,280 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,867,311 | 884,600 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,386,055 | 785,632 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,143,711 | 474,998 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,871,587 | 432,128 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $10,131,017 | 425,673 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,413,472 | 528,157 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,624,299 | 456,219 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,308,496 | 253,631 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,815,707 | 85,971 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,979,501 | 77,780 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,175,067 | 48,900 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,052,697 | 54,714 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $721,860 | 41,534 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $691,417 | 31,586 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $213,538 | 9,550 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $613,156 | 27,570 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $282,358 | 19,130 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $159,759 | 10,780 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $247,702 | 22,580 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||